APA

Chatterjee M., Turner D. C., Felip E., Lena H., Cappuzzo F., Horn L., Garon E. B., Hui R., Arkenau H., Gubens M. A., Hellmann M. D., Dong D., Li C., Mayawala K., Freshwater T., Ahamadi M., Stone J., Lubiniecki G. M., Zhang J., Im E., De Alwis D. P., Kondic A. G. & Fløtten Ø. (20171227). Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Chatterjee M, Turner D C, Felip E, Lena H, Cappuzzo F, Horn L, Garon E B, Hui R, Arkenau H-T, Gubens M A, Hellmann M D, Dong D, Li C, Mayawala K, Freshwater T, Ahamadi M, Stone J, Lubiniecki G M, Zhang J, Im E, De Alwis D P, Kondic A G and Fløtten Ø. 20171227. Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Chatterjee M., Turner D. C., Felip E., Lena H., Cappuzzo F., Horn L., Garon E. B., Hui R., Arkenau H., Gubens M. A., Hellmann M. D., Dong D., Li C., Mayawala K., Freshwater T., Ahamadi M., Stone J., Lubiniecki G. M., Zhang J., Im E., De Alwis D. P., Kondic A. G. and Fløtten Ø. (20171227). Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Chatterjee M, Turner D C, Felip E, Lena H, Cappuzzo F, Horn L, Garon E B, Hui R, Arkenau H-T, Gubens M A, Hellmann M D, Dong D, Li C, Mayawala K, Freshwater T, Ahamadi M, Stone J, Lubiniecki G M, Zhang J, Im E, De Alwis D P, Kondic A G and Fløtten Ø. Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20171227.